Moreover, NatD has been found to be significantly downregulated in hepatocellular carcinoma samples and is implicated in apoptosis regulation [9, 10], while the NatC catalytic subunit NAA30 is highly expressed in glioblastoma patients [11]. The gene discussed is NAA10; the disease is hepatocellular carcinoma.